1. Sales Orders Taken • Record sales orders of $63.4 million, up +22% on FY24 • Sleep & Neurology segment orders rose +39% to $53.0 million, led by US Sleep Diagnostics growth (+102% to $23.5 million) • Somfit + Nexus 360 SaaS orders increased to $6.7 million, up +49%, with US Somfit sales orders rising +675% from $0.4 million to $3.1 million • MEG orders totalled $5.9 million, with three systems in progress for reported revenue in FY26 (valued at approximately $15 million) • Geographically, the US continued to lead growth, with FY25 sales orders up +115% on FY24. Asia increased +71%, and Europe was up +12% compared to the prior year 2. Revenue Reported (Unaudited) • Record reported revenue of $51.0 million, up +4% on FY24 • Sleep & Neurology segment revenue grew to $46.3 million, up +16% on FY24, • Somfit + Nexus 360 (SaaS) segment revenue contributed $6.0 million, up +41% on FY24 • No MEG revenue in FY25, compared to one system delivered in FY24
CMP Price at posting:
30.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)